VYCO
VYCOR MEDICAL INCCompany Information
- Company Name
- VYCOR MEDICAL INC
- CIK
- CIK0001424768
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- VYCO: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- VYCO
SEC filing data through
Insider Sentiment
- Last purchase
- 2014-12-31
- Last sale
- 2014-07-01
- Shares purchased (TTM)
- 984,040
- Shares sold (TTM)
- 6,241
Institutional Sentiment
- As of
- 2017-12-31
- Institutional shares owned
- 500
- Shares outstanding
- 19,821,988
- Ownership
- 0.00%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -2.90%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Of Disposal Group Including Discontinued Operation Current | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Other Assets | ||||||||||||||||||
| Inventory Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | 0 | - | ||||||
| Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 5 | 4 | 4 | 4 | 4 | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Liability Noncurrent | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Long Term Loans From Bank | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Treasury Stock Value | - | - | - | - | - | - | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Additional Paid In Capital | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | 29 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -3 | -3 | ||||||
| Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | - | - | - | - | - | ||||||
| Retained Earnings Accumulated Deficit | -34 | -34 | -34 | -34 | -33 | -33 | -33 | -33 | -33 | -33 | -33 | -33 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities And Stockholders Equity | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 55 | 55 | 55 | 55 | 55 | 55 | 55 | 55 | 55 | 55 | 55 | 55 | ||||||
| Common Stock Shares Issued | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | ||||||
| Shares Outstanding | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVYCOR MEDICAL INC (VYCO) — SEC Financial Statements & Analysis
VYCOR MEDICAL INC (VYCO) is a surgical & medical instruments & apparatus company, incorporated in DE. VYCOR MEDICAL INC trades on OTC as: VYCO. VYCOR MEDICAL INC (VYCO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, VYCOR MEDICAL INC carries a market cap of $2.20M, a P/E ratio of 21.54x, a P/B ratio of -0.52x, a P/S ratio of 1.22x, an enterprise value of $2.04M, and an EV/EBITDA multiple of 19.13x. On profitability, it posts a gross margin of 83.37%, an operating margin of 2.67%, a net margin of 5.66%, a Return on Equity (ROE) of -2.52%, and a Return on Assets (ROA) of 12.09%. Per share, it reports EPS of $0.00, diluted EPS of $0.00, free cash flow per share of $0.00, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 1.61% year-over-year, net income growth of -125.21% year-over-year, and EPS growth of -125.21% year-over-year. On the balance sheet, it maintains a current ratio of 0.13x, a quick ratio of 0.07x, working capital of $-4.29M, a debt-to-equity ratio of -1.19x, a debt ratio of 6.23, an interest coverage ratio of 0.96x, free cash flow of $59.78K (TTM), and net debt of $-158.91K. Figures sourced from SEC EDGAR.
- Market Cap
- $2.20M
- P/E TTM
- 21.54x
- EPS TTM
- $0.00
- P/B TTM
- -0.52x
- ROE TTM
- -2.52%
- ROA TTM
- 12.09%
- Debt To Equity
- -1.19x
- Free Cash Flow TTM
- $59.78K
- Net Revenue TTM Growth 1Y
- 1.61%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is VYCOR MEDICAL INC in?
VYCOR MEDICAL INC (VYCO) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does VYCO trade on?
VYCOR MEDICAL INC (VYCO) trades on the OTC.
Where is VYCOR MEDICAL INC incorporated?
VYCOR MEDICAL INC is incorporated in DE.
When was VYCOR MEDICAL INC (VYCO)'s most recent SEC filing?
VYCOR MEDICAL INC (VYCO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is VYCO's market cap?
VYCOR MEDICAL INC (VYCO) has a market capitalization of $2.20M as of 2026-06-30.
What is VYCO's P/E ratio?
VYCOR MEDICAL INC (VYCO)'s trailing twelve month P/E ratio is 21.54x as of 2026-06-30.
What is VYCO's EPS (earnings per share)?
VYCOR MEDICAL INC (VYCO)'s trailing twelve month EPS is $0.00 as of 2026-06-30.
What is VYCO's ROE (return on equity)?
VYCOR MEDICAL INC (VYCO)'s trailing twelve month Return on Equity (ROE) is -2.52% as of 2026-06-30.
What is VYCO's ROA (return on assets)?
VYCOR MEDICAL INC (VYCO)'s trailing twelve month Return on Assets (ROA) is 12.09% as of 2026-06-30.
What is VYCO's EV/EBITDA?
VYCOR MEDICAL INC (VYCO)'s trailing twelve month EV/EBITDA is 19.13x as of 2026-06-30.